Literature DB >> 12235224

Principles of clinical trial design.

Michelle Nottage1, Lillian L Siu.   

Abstract

Mesh：

Year:  2002        PMID： 12235224

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.

Authors:  Roland B Walter; Frederick R Appelbaum; Martin S Tallman; Noel S Weiss; Richard A Larson; Elihu H Estey
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

Review 2.  Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice?

Authors:  Davide Tassinari; Marco Maltoni; Sergio Sartori; Manuela Fantini; Barbara Poggi; Alberto Ravaioli
Journal:  Support Care Cancer       Date:  2004-12-03       Impact factor: 3.603

3.  Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews.

Authors:  John K Chan; Tuyen K Kiet; Bradley J Monk; Nichole Young-Lin; Kevin Blansit; Daniel S Kapp; Idoroenyi Amanam
Journal:  Oncologist       Date:  2014-03-05

4.  Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib.

Authors:  Xiaoqin Li; Shan Liu; Hangang Gu; Deqiang Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-05       Impact factor: 4.553

Review 5.  Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics.

Authors:  Salvador Fudio; Alvaro Sellers; Laura Pérez Ramos; Beatriz Gil-Alberdi; Ali Zeaiter; Mikel Urroz; Antonio Carcas; Rubin Lubomirov
Journal:  Cancer Chemother Pharmacol       Date:  2022-08-27       Impact factor: 3.288

6.  Reporting trends of outcome measures in phase II and phase III trials conducted in advanced-stage non-small-cell lung cancer.

Authors:  Saurav Ghimire; Eunjung Kyung; Eunyoung Kim
Journal:  Lung       Date:  2013-05-30       Impact factor: 2.584

Review 7.  Current status and perspectives of patient-derived rare cancer models.

Authors:  Tadashi Kondo
Journal:  Hum Cell       Date:  2020-06-14       Impact factor: 4.174

8.  Opportunities and challenges for junior investigators conducting pain clinical trials.

Authors:  Meredith C B Adams; Mark C Bicket; Jamie D Murphy; Christopher L Wu; Robert W Hurley
Journal:  Pain Rep       Date:  2019 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.